Which has higher earnings and valuation, HQY or ITGR?

HealthEquity has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 5.42 $215.20M $2.67 31.91 Integer $1.85B 1.67 $102.81M $4.01 22.68

Is HQY or ITGR more profitable?

HealthEquity has a net margin of 17.25% compared to Integer's net margin of 7.64%. HealthEquity's return on equity of 14.75% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% Integer 7.64% 12.83% 6.51%

Which has stronger earnings & valuation, FTAI or HQY?

FTAI Aviation has higher revenue and earnings than HealthEquity. HealthEquity is trading at a lower price-to-earnings ratio than FTAI Aviation, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio FTAI Aviation $2.51B 11.30 $501.06M $5.04 54.78 HealthEquity $1.31B 5.42 $215.20M $2.67 31.91

Does the media refer more to FTAI or HQY?

In the previous week, FTAI Aviation had 3 more articles in the media than HealthEquity. MarketBeat recorded 9 mentions for FTAI Aviation and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.57 beat FTAI Aviation's score of 1.33 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FTAI Aviation 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings & valuation, HQY or AER?

Aercap has higher revenue and earnings than HealthEquity. Aercap is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 5.42 $215.20M $2.67 31.91 Aercap $8.52B 2.84 $3.75B $22.82 6.36

Is HQY or AER more profitable?

Aercap has a net margin of 45.22% compared to HealthEquity's net margin of 17.25%. Aercap's return on equity of 16.01% beat HealthEquity's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% Aercap 45.22% 16.01% 4.04%

Does the media prefer HQY or AER?

In the previous week, HealthEquity had 1 more articles in the media than Aercap. MarketBeat recorded 6 mentions for HealthEquity and 5 mentions for Aercap. HealthEquity's average media sentiment score of 1.57 beat Aercap's score of 1.24 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Aercap 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, HQY or CPAY?

Corpay has higher revenue and earnings than HealthEquity. Corpay is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 5.42 $215.20M $2.67 31.91 Corpay $4.53B 4.99 $1.07B $16.71 20.67

Does the media refer more to HQY or CPAY?

In the previous week, Corpay had 5 more articles in the media than HealthEquity. MarketBeat recorded 11 mentions for Corpay and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.57 beat Corpay's score of 0.33 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Corpay 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, ULS or HQY?

UL Solutions has higher revenue and earnings than HealthEquity. HealthEquity is trading at a lower price-to-earnings ratio than UL Solutions, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio UL Solutions $3.05B 6.03 $325M $1.71 53.38 HealthEquity $1.31B 5.42 $215.20M $2.67 31.91

Is ULS or HQY more profitable?

HealthEquity has a net margin of 17.25% compared to UL Solutions' net margin of 11.24%. UL Solutions' return on equity of 30.99% beat HealthEquity's return on equity. Company Net Margins Return on Equity Return on Assets UL Solutions 11.24% 30.99% 13.15% HealthEquity 17.25% 14.75% 9.22%

Does the media favor ULS or HQY?

In the previous week, UL Solutions had 4 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for UL Solutions and 6 mentions for HealthEquity. UL Solutions' average media sentiment score of 1.59 beat HealthEquity's score of 1.57 indicating that UL Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UL Solutions 9 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive HealthEquity 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

HealthEquity (HQY) Competitors

$85.21 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$82.50 -2.71 (-3.17%)

As of 06/18/2026 07:03 PM Eastern

Compare

HQY vs. ITGR, FTAI, AER, CPAY, and ULS

Should you buy HealthEquity stock or one of its competitors? MarketBeat compares HealthEquity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HealthEquity include Integer (ITGR), FTAI Aviation (FTAI), Aercap (AER), Corpay (CPAY), and UL Solutions (ULS).

How does HealthEquity compare to Integer?

HealthEquity (NASDAQ:HQY) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Integer has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

HealthEquity presently has a consensus price target of $110.57, indicating a potential upside of 29.76%. Integer has a consensus price target of $98.71, indicating a potential upside of 8.54%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27

In the previous week, HealthEquity had 6 more articles in the media than Integer. MarketBeat recorded 6 mentions for HealthEquity and 0 mentions for Integer. HealthEquity's average media sentiment score of 1.57 beat Integer's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media.

Company	Overall Sentiment
HealthEquity	Very Positive
Integer	Neutral

HealthEquity has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91
Integer	$1.85B	1.67	$102.81M	$4.01	22.68

HealthEquity has a net margin of 17.25% compared to Integer's net margin of 7.64%. HealthEquity's return on equity of 14.75% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Integer	7.64%	12.83%	6.51%

Summary

HealthEquity beats Integer on 14 of the 17 factors compared between the two stocks.

How does HealthEquity compare to FTAI Aviation?

FTAI Aviation (NASDAQ:FTAI) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

FTAI Aviation has higher revenue and earnings than HealthEquity. HealthEquity is trading at a lower price-to-earnings ratio than FTAI Aviation, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FTAI Aviation	$2.51B	11.30	$501.06M	$5.04	54.78
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91

FTAI Aviation has a net margin of 18.92% compared to HealthEquity's net margin of 17.25%. FTAI Aviation's return on equity of 181.43% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FTAI Aviation	18.92%	181.43%	12.45%
HealthEquity	17.25%	14.75%	9.22%

FTAI Aviation currently has a consensus price target of $326.88, suggesting a potential upside of 18.39%. HealthEquity has a consensus price target of $110.57, suggesting a potential upside of 29.76%. Given HealthEquity's higher probable upside, analysts plainly believe HealthEquity is more favorable than FTAI Aviation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FTAI Aviation	0 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.91
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86

89.0% of FTAI Aviation shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 1.4% of FTAI Aviation shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

FTAI Aviation has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

In the previous week, FTAI Aviation had 3 more articles in the media than HealthEquity. MarketBeat recorded 9 mentions for FTAI Aviation and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.57 beat FTAI Aviation's score of 1.33 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FTAI Aviation	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

FTAI Aviation beats HealthEquity on 11 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Aercap?

HealthEquity (NASDAQ:HQY) and Aercap (NYSE:AER) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Aercap has higher revenue and earnings than HealthEquity. Aercap is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91
Aercap	$8.52B	2.84	$3.75B	$22.82	6.36

In the previous week, HealthEquity had 1 more articles in the media than Aercap. MarketBeat recorded 6 mentions for HealthEquity and 5 mentions for Aercap. HealthEquity's average media sentiment score of 1.57 beat Aercap's score of 1.24 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Aercap	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Aercap has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

HealthEquity currently has a consensus target price of $110.57, suggesting a potential upside of 29.76%. Aercap has a consensus target price of $163.13, suggesting a potential upside of 12.48%. Given HealthEquity's stronger consensus rating and higher probable upside, equities research analysts plainly believe HealthEquity is more favorable than Aercap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Aercap	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 96.4% of Aercap shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 0.5% of Aercap shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Aercap has a net margin of 45.22% compared to HealthEquity's net margin of 17.25%. Aercap's return on equity of 16.01% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Aercap	45.22%	16.01%	4.04%

Summary

HealthEquity beats Aercap on 11 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Corpay?

HealthEquity (NASDAQ:HQY) and Corpay (NYSE:CPAY) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Corpay has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Corpay has a net margin of 24.60% compared to HealthEquity's net margin of 17.25%. Corpay's return on equity of 38.68% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Corpay	24.60%	38.68%	6.46%

Corpay has higher revenue and earnings than HealthEquity. Corpay is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91
Corpay	$4.53B	4.99	$1.07B	$16.71	20.67

HealthEquity presently has a consensus price target of $110.57, indicating a potential upside of 29.76%. Corpay has a consensus price target of $383.07, indicating a potential upside of 10.91%. Given HealthEquity's stronger consensus rating and higher possible upside, equities analysts plainly believe HealthEquity is more favorable than Corpay.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Corpay	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 98.8% of Corpay shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 5.2% of Corpay shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Corpay had 5 more articles in the media than HealthEquity. MarketBeat recorded 11 mentions for Corpay and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.57 beat Corpay's score of 0.33 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Corpay	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Corpay beats HealthEquity on 9 of the 17 factors compared between the two stocks.

How does HealthEquity compare to UL Solutions?

UL Solutions (NYSE:ULS) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

99.6% of HealthEquity shares are held by institutional investors. 1.2% of UL Solutions shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

UL Solutions has higher revenue and earnings than HealthEquity. HealthEquity is trading at a lower price-to-earnings ratio than UL Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UL Solutions	$3.05B	6.03	$325M	$1.71	53.38
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91

UL Solutions has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

HealthEquity has a net margin of 17.25% compared to UL Solutions' net margin of 11.24%. UL Solutions' return on equity of 30.99% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UL Solutions	11.24%	30.99%	13.15%
HealthEquity	17.25%	14.75%	9.22%

UL Solutions currently has a consensus price target of $101.54, indicating a potential upside of 11.25%. HealthEquity has a consensus price target of $110.57, indicating a potential upside of 29.76%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than UL Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UL Solutions	0 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.64
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, UL Solutions had 4 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for UL Solutions and 6 mentions for HealthEquity. UL Solutions' average media sentiment score of 1.59 beat HealthEquity's score of 1.57 indicating that UL Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UL Solutions	9 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
HealthEquity	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

UL Solutions beats HealthEquity on 9 of the 16 factors compared between the two stocks.

Get HealthEquity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQY vs. The Competition

Export

Metric	HealthEquity	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.12B	$8.76B	$6.43B	$12.60B
Dividend Yield	N/A	1.73%	2.68%	5.81%
P/E Ratio	31.91	24.73	24.75	24.44
Price / Sales	5.42	17.77	529.79	110.16
Price / Cash	16.15	102.97	45.07	55.09
Price / Book	3.48	5.64	10.80	6.58
Net Income	$215.20M	$179.69M	$3.57B	$337.17M
7 Day Performance	-3.54%	1.96%	0.72%	0.83%
1 Month Performance	-1.41%	2.99%	0.41%	2.25%
1 Year Performance	-15.88%	6.36%	29.34%	36.14%

HealthEquity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQY HealthEquity	4.859 of 5 stars	$85.21 flat	$110.57 +29.8%	-15.9%	$7.12B	$1.31B	31.91	2,814	Positive News
ITGR Integer	1.6185 of 5 stars	$91.79 -0.2%	$98.71 +7.5%	-22.9%	$3.12B	$1.85B	22.89	11,000
FTAI FTAI Aviation	4.4756 of 5 stars	$230.46 -1.5%	$326.88 +41.8%	+113.9%	$24.01B	$2.51B	45.73	40	Positive News Gap Up
AER Aercap	4.202 of 5 stars	$135.63 -1.0%	$163.13 +20.3%	+25.9%	$22.85B	$8.52B	5.94	740	News Coverage Positive News
CPAY Corpay	3.8144 of 5 stars	$348.74 +0.4%	$383.07 +9.8%	+9.2%	$22.71B	$4.53B	20.87	11,800	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HQY) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Competitors

HQY vs. ITGR, FTAI, AER, CPAY, and ULS

How does HealthEquity compare to Integer?

Summary

How does HealthEquity compare to FTAI Aviation?

Summary

How does HealthEquity compare to Aercap?

Summary

How does HealthEquity compare to Corpay?

Summary

How does HealthEquity compare to UL Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthEquity (HQY) Competitors

HQY vs. ITGR, FTAI, AER, CPAY, and ULS

How does HealthEquity compare to Integer?

Do insiders & institutionals have more ownership in HQY or ITGR?

Which has more risk & volatility, HQY or ITGR?

Do analysts prefer HQY or ITGR?

Does the media favor HQY or ITGR?

Which has higher earnings and valuation, HQY or ITGR?

Is HQY or ITGR more profitable?

Summary

How does HealthEquity compare to FTAI Aviation?

Which has stronger earnings & valuation, FTAI or HQY?

Is FTAI or HQY more profitable?

Do analysts recommend FTAI or HQY?

Do insiders and institutionals believe in FTAI or HQY?

Which has more risk & volatility, FTAI or HQY?

Does the media refer more to FTAI or HQY?

Summary

How does HealthEquity compare to Aercap?

Which has stronger earnings & valuation, HQY or AER?

Does the media prefer HQY or AER?

Which has more volatility & risk, HQY or AER?

Do analysts recommend HQY or AER?

Do insiders & institutionals hold more shares of HQY or AER?

Is HQY or AER more profitable?

Summary

How does HealthEquity compare to Corpay?

Which has more risk & volatility, HQY or CPAY?

Is HQY or CPAY more profitable?

Which has stronger earnings and valuation, HQY or CPAY?

Do analysts recommend HQY or CPAY?

Do institutionals & insiders have more ownership in HQY or CPAY?

Does the media refer more to HQY or CPAY?

Summary

How does HealthEquity compare to UL Solutions?

Do institutionals & insiders have more ownership in ULS or HQY?

Which has better valuation and earnings, ULS or HQY?

Which has more risk & volatility, ULS or HQY?

Is ULS or HQY more profitable?

Do analysts prefer ULS or HQY?

Does the media favor ULS or HQY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools